C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP
TED · 569185-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 1 | €1,899,000 | 2026-06-19 |
| Takeda Farmacêuticos Portugal, Lda | 1 | €1,828,250 | 2026-07-17 |
| Cencora 3PL Portugal, S.A. | 1 | €1,435,097 | 2026-07-20 |
| Getinge Group Portuga, Unipessoal, Lda. | Iberdata Equipamentos, SA | 1 | €1,412,619 | 2026-05-21 |
| General Electric Healthcare Portugal, Sociedade Unipessoal, Lda, | 1 | €851,700 | 2026-06-02 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição do medicamento LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-28 | 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-07-07 | 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-08-04 | 2024/0900 - DOLUTEGRAVIR [50 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-08-11 | 2023/0492 - DURVALUMAB [50 MG/ ML 10 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 92% |
| 2026-06-25 | Suministro de Medicamento Exclusivo-Dolutegravir sodio 50 mg / Lamivudina 300 mg comprimidos | SERVICIO DE SALUD DEL PRINCIPADO DE ASTURIAS ES | 92% |